Tel:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@anticorps-enligne.fr

Recombinant SARS-CoV-2 (SARS-CoV-2/ 2019-nCoV) S (AA 16-685) anticorps (Fc Tag,FITC)

L’anticorps Souris Monoclonal anti- a été validé pour ELISA. Il convient pour détecter dans des échantillons de SARS Coronavirus-2 (SARS-CoV-2).
N° du produit ABIN6953154

Aperçu rapide pour Recombinant SARS-CoV-2 (SARS-CoV-2/ 2019-nCoV) S (AA 16-685) anticorps (Fc Tag,FITC) (ABIN6953154)

Antigène

SARS-CoV-2 (SARS-CoV-2/ 2019-nCoV) S

Type d'anticorp

Recombinant Antibody

Fragment

scFv fragment

Reactivité

SARS Coronavirus-2 (SARS-CoV-2)

Hôte

  • 3
  • 1
Souris

Clonalité

  • 2
  • 2
Monoclonal

Conjugué

  • 1
  • 1
  • 1
  • 1
Fc Tag,FITC

Application

  • 4
  • 2
  • 1
ELISA

Clone

H6
  • Épitope

    AA 16-685

    Fonction

    S Recombinant Monoclonal Antibody, FITC conjugated

    Attributs du produit

    Recombinant anti-SARS-CoV-2 spike Mouse ScFv is expressed from 293 cells (HEK293) with a human IgG1 Fc tag on C-terminal.
    Mouse scFv fusion with human IgG1 Fc
    AA 16-685

    Purification

    Affinity-chromatography

    Immunogène

    Recombinant Human Novel Coronavirus Spike glycoprotein (S) (16-685aa) (CSB-MP3324GMY)

    Isotype

    IgG1
  • Indications d'application

    Optimal working dilution should be determined by the investigator.

    Restrictions

    For Research Use only
  • Format

    Liquid

    Buffer

    Preservative: 0.03 % Proclin 300
    Constituents: 50 % Glycerol, 0.01M PBS, PH 7.4

    Agent conservateur

    ProClin

    Précaution d'utilisation

    This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

    Stock

    -20 °C,-80 °C

    Stockage commentaire

    Upon receipt, store at -20°C or -80°C. Avoid repeated freeze
  • Antigène

    SARS-CoV-2 (SARS-CoV-2/ 2019-nCoV) S

    Sujet

    Spike glycoprotein comprises two functional subunits responsible for binding to the host cell receptor (S1 subunit) and fusion of the viral and cellular membranes (S2 subunit). For many coronavirus (CoVs), S is cleaved at the boundary between the S1 and S2 subunits, which remain non-covalently bound in the prefusion conformation. The distal S1 subunit comprises the receptor-binding domain(s) and contributes to stabilization of the prefusion state of the membrane-anchored S2 subunit that contains the fusion machinery. S is further cleaved by host proteases at the so-called S2' site located immediately upstream of the fusion peptide in all CoVs. This cleavage has been proposed to activate the protein for membrane fusion via extensive irreversible conformational changes. However, different CoVs use distinct domains within the S1 subunit to recognize a variety of attachment and entry receptors, depending on the viral species. Endemic human coronaviruses OC43 and HKU1 attach via their S domain A to 5-N-acetyl-9-O-acetyl-sialosides found on glycoproteins and glycolipids at the host cell surface to enable entry into susceptible cells. MERS-CoV S uses domain A to recognize non-acetylated sialoside attachment receptors, which likely promote subsequent binding of domain B to the entry receptor, dipeptidyl-peptidase 4. SARS-CoV and several SARS-related coronaviruses (SARSr-CoV) interact directly with angiotensin-converting enzyme 2 (ACE2) via SB to enter target cells.

    ID gène

    43740568

    UniProt

    P0DTC2
Vous êtes ici:
Chat with us!